Recent Biotechnology Acquisitions in Kansas
Acquisition Volume in Biotechnology in Kansas by Year
Last 5 years
Actual
Full-year estimate
-
September 12, 2022
- Buyer
- BioIVT
- Target
- XenoTech
- Seller
- Sekisui Chemical
- Industry
- Biotechnology
- Location
- Kansas, United States
- Type
- Divestiture
BioIVT has acquired XenoTech, a Kansas City–based provider of ADME‑Tox in vitro models and contract research services, from Sekisui Chemical. The acquisition expands BioIVT's hepatic product portfolio and ADME/DMPK capabilities to better support biopharma customers' preclinical testing needs. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.